Concurrent chemoradiotherapy improves survival outcome in muscle-invasive bladder cancer
Sang Jun Byun, Jin Hee Kim, Young Kee Oh, Byung Hoon Kim
Radiat Oncol J. 2015;33(4):294-300. Published online 2015 Dec 30 DOI: https://doi.org/10.3857/roj.2015.33.4.294
Citations to this article as recorded by 
Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle‐invasive bladder cancer
Nai‐Wen Kang, Yin‐Hsun Feng, Kuei‐Li Lin, Yi‐Chen Chen, Chung‐Han Ho, Ching‐Chieh Yang
Cancer Medicine.2024;[Epub] CrossRef
LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer
Peng Zhang, Xiaodu Xie, Chunming Li, Chaohua Zhang, Peihe Liang
Cancer Medicine.2023; 12(19): 19758. CrossRef
Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
Victor M. Schuettfort, Benjamin Pradere, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Margit Fisch, David D’Andrea, Michael Rink, Paolo Gontero, Francesco Soria, Shahrokh F. Shariat
World Journal of Urology.2021; 39(6): 1757. CrossRef
Clinical therapies and nano drug delivery systems for urinary bladder cancer
Pooja Jain, Himanshu Kathuria, Munira Momin
Pharmacology & Therapeutics.2021; 226: 107871. CrossRef
Survival Impact of Current-Smoking-Related COPD or COPD with Acute Exacerbation on Bladder Preservation through Concurrent Chemoradiotherapy for Muscle-Invasive Bladder Urothelial Carcinoma
Jiaqiang Zhang, Shyh-Chyi Chang, Ming-Feng Chiang, Kuo-Chin Chiu, Szu-Yuan Wu
Journal of Personalized Medicine.2021; 11(10): 958. CrossRef
Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
Hui Ding, Ning Fan, Zhongyun Ning, Deyuan Ma
Frontiers in Oncology.2020;[Epub] CrossRef
A multi-institutional study of bladder-preserving therapy for stage II-IV bladder cancer: A Korean Radiation Oncology Group Study (KROG 14-16)
Sang Jun Byun, Won Park, Kwan Ho Cho, Jaeho Cho, Ah Ram Chang, Ki Mun Kang, Jin Ho Kim, Jin Hee Kim, Mitesh J. Borad
PLOS ONE.2019; 14(1): e0209998. CrossRef
Modern possibilities of organ-preserving treatment of patients with muscle-invasive bladder cancer
Vladimir J. Startsev, Ivan N. Dilenok, Timur R. Dzhemilev
Urologicheskie vedomosti.2019; 9(1): 29. CrossRef
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
Omar Fahmy, Mohd Ghani Khairul-Asri, Tina Schubert, Markus Renninger, Rohan Malek, Hubert Kübler, Arnulf Stenzl, Georgios Gakis
Urologic Oncology: Seminars and Original Investigations.2018; 36(2): 43. CrossRef
Trimodal therapy for muscle-invasive bladder cancer
Joachim Mathes, Steffen Rausch, Tilman Todenhöfer, Arnulf Stenzl
Expert Review of Anticancer Therapy.2018; 18(12): 1219. CrossRef
Effect of body thickness on helical and direct treatment delivery modes: a phantom study
Hiroya Ito
Journal of Rural Medicine.2018; 13(2): 110. CrossRef
Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis
Yeon Joo Kim, Sang Jun Byun, Hanjong Ahn, Choung-Soo Kim, Beom-Sik Hong, Sangjun Yoo, Jae-Lyun Lee, Young Seok Kim
Oncotarget.2017; 8(40): 68996. CrossRef